GlycoMimetics
+$0.07 (+7.01%) Today
-$0.01 (-0.45%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.
About GLYC
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.
CEO
Harout Semerjian
Employees
54
Headquarters
Rockville, Maryland
Founded
2003
GLYC Key Statistics
Market cap
59.24M
Price-Earnings ratio
—
Dividend yield
—
Average volume
265.76K
High today
$1.15
Low today
$1.03
Open price
$1.07
Volume
347.10K
52 Week high
$4.40
52 Week low
$1.02
GLYC Earnings
-$0.38
-$0.25
-$0.13
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 1, Pre-Market